Roche: Is Continuous Drug Delivery the Key to Transforming Long-term Outcomes in Retinal Diseases?
Location: 115
Date & Time: Saturday, 21 September, 13:00 - 14:00 CEST
Chairperson(s): M. Figueroa, SPAIN
Speakers:
Presentations:
M. Figueroa SPAIN
13:00 Welcome and opening remarks
M. Figueroa SPAIN,
R. Hillier UK
13:03 Where is the place for continuous drug delivery in the changing retinal landscape?
J. Graff USA,
M. Chang USA
13:15 What is the benefit of continuous drug delivery?
M. Figueroa SPAIN,
J. Graff USA,
M. Chang USA,
R. Hillier UK
13:25 Panel discussion
M. Chang USA
13:30 What is the patient experience of continuous drug delivery?
J. Graff USA
13:34 What is the real-world impact of continuous drug delivery?
R. Hillier UK
13:40 What does the future hold with continuous drug delivery?
M. Figueroa SPAIN,
J. Graff USA,
M. Chang USA,
R. Hillier UK
13:43 Panel discussion, including Q&A
M. Figueroa SPAIN
13:58 Is continuous drug delivery the key to transforming long-term outcomes in retinal diseases?
This is a promotional symposium for HCPs only. Presentations and materials disclosed during the event are subject to Intellectual Property Rights. Total or partial reproduction or use of this content requires prior AbbVie authorization. Furthermore, in order to comply with the regulations regarding the promotion of medicines, we ask you not to share its contents on your social networks. Please do not distribute in media, or communication channels aimed at the general public.